3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice
出版年份 2019 全文链接
标题
3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL MEDICINE
Volume -, Issue -, Pages jem.20181035
出版商
Rockefeller University Press
发表日期
2019-01-16
DOI
10.1084/jem.20181035
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology
- (2018) Finn Peters et al. ACTA NEUROPATHOLOGICA
- PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke
- (2018) Ranjeet K. Sinha et al. BLOOD
- Activated protein C, protease activated receptor 1, and neuroprotection
- (2018) John H. Griffin et al. BLOOD
- BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions
- (2018) Xiangyou Hu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice
- (2018) WonHee Kim et al. Molecular Neurodegeneration
- Pericyte degeneration causes white matter dysfunction in the mouse central nervous system
- (2018) Axel Montagne et al. NATURE MEDICINE
- Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C
- (2018) Arun Paul Amar et al. NEUROPHARMACOLOGY
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activ
- (2018) Patrick Lyden et al. ANNALS OF NEUROLOGY
- Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
- (2017) Axel Montagne et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease
- (2017) M. M. Mariani et al. Scientific Reports
- Annexin A1 restores Aβ1-42-induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway
- (2016) Jong-Chan Park et al. AGING CELL
- 2016 Scientific Sessions Sol Sherry Distinguished Lecturer in ThrombosisHighlights
- (2016) John H. Griffin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 3K3A–activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice
- (2016) Yaoming Wang et al. NATURE MEDICINE
- Cerebrovascular pathology during the progression of experimental Alzheimer's disease
- (2016) Patrizia Giannoni et al. NEUROBIOLOGY OF DISEASE
- Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for Neuroprotection
- (2016) Patrick Lyden et al. STROKE
- High‐Fat‐Diet Intake Enhances Cerebral Amyloid Angiopathy and Cognitive Impairment in a Mouse Model of Alzheimer's Disease, Independently of Metabolic Disorders
- (2016) Bowen Lin et al. Journal of the American Heart Association
- Activated protein C: biased for translation
- (2015) J. H. Griffin et al. BLOOD
- Beneficial Effects of the β-Secretase Inhibitor GRL-8234 in 5XFAD Alzheimer’s Transgenic Mice Lessen During Disease Progression
- (2015) Latha Devi et al. Current Alzheimer Research
- Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages
- (2015) L. Devi et al. NEUROSCIENCE
- Phase 1 Safety, Tolerability and Pharmacokinetics of 3K3A-APC in Healthy Adult Volunteers
- (2014) Patrick Lyden et al. CURRENT PHARMACEUTICAL DESIGN
- Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice
- (2014) E. A. Winkler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytoprotective-selective activated protein C therapy for ischaemic stroke
- (2014) Berislav Zlokovic et al. THROMBOSIS AND HAEMOSTASIS
- BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
- (2014) Robert Vassar Alzheimers Research & Therapy
- Activated protein C inhibits amyloid β production via promoting expression of ADAM-10
- (2013) Bing Li et al. BRAIN RESEARCH
- A Lipoprotein Receptor Cluster IV Mutant Preferentially Binds Amyloid-β and Regulates Its Clearance from the Mouse Brain
- (2013) Abhay P. Sagare et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An Activated Protein C Analog Stimulates Neuronal Production by Human Neural Progenitor Cells via a PAR1-PAR3-S1PR1-Akt Pathway
- (2013) H. Guo et al. JOURNAL OF NEUROSCIENCE
- ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function
- (2013) Jaehong Suh et al. NEURON
- Area-Specific Alterations of Synaptic Plasticity in the 5XFAD Mouse Model of Alzheimer’s Disease: Dissociation between Somatosensory Cortex and Hippocampus
- (2013) Nadine Crouzin et al. PLoS One
- Activated Protein C Analog Protects From Ischemic Stroke and Extends the Therapeutic Window of Tissue-Type Plasminogen Activator in Aged Female Mice and Hypertensive Rats
- (2013) Yaoming Wang et al. STROKE
- Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke
- (2012) Patricia D. Williams et al. CURRENT PHARMACEUTICAL DESIGN
- A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease
- (2012) Rashid Deane et al. JOURNAL OF CLINICAL INVESTIGATION
- A 1-42-RAGE Interaction Disrupts Tight Junctions of the Blood-Brain Barrier Via Ca2+-Calcineurin Signaling
- (2012) S.-Y. Kook et al. JOURNAL OF NEUROSCIENCE
- BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s disease
- (2012) Linda Chami et al. Molecular Neurodegeneration
- An Activated Protein C Analog With Reduced Anticoagulant Activity Extends the Therapeutic Window of Tissue Plasminogen Activator for Ischemic Stroke in Rodents
- (2012) Yaoming Wang et al. STROKE
- Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
- (2011) Chia-Hsiung Chen et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cytoprotective protein C pathways and implications for stroke and neurological disorders
- (2011) Berislav V. Zlokovic et al. TRENDS IN NEUROSCIENCES
- Activated protein C analog with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact
- (2010) Corey T. Walker et al. BRAIN RESEARCH
- ADAM10 is the physiologically relevant, constitutive α-secretase of the amyloid precursor protein in primary neurons
- (2010) Peer-Hendrik Kuhn et al. EMBO JOURNAL
- Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer’s disease transgenic mice
- (2010) Ryoichi Kimura et al. JOURNAL OF NEUROCHEMISTRY
- Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
- (2010) Daniel Paris et al. Journal of Neuroinflammation
- The Disintegrin/Metalloproteinase ADAM10 Is Essential for the Establishment of the Brain Cortex
- (2010) E. Jorissen et al. JOURNAL OF NEUROSCIENCE
- Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease
- (2010) Sadim Jawhar et al. NEUROBIOLOGY OF AGING
- Fibrinogen and β-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer's Disease
- (2010) Marta Cortes-Canteli et al. NEURON
- Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging
- (2010) Robert D. Bell et al. NEURON
- Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity
- (2009) Huang Guo et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells
- (2009) Zhihui Zhong et al. JOURNAL OF CLINICAL INVESTIGATION
- Species-dependent neuroprotection by activated protein C mutants with reduced anticoagulant activity
- (2009) Huang Guo et al. JOURNAL OF NEUROCHEMISTRY
- Activated Protein C is Neuroprotective and Mediates New Blood Vessel Formation and Neurogenesis After Controlled Cortical Impact
- (2009) Anthony L. Petraglia et al. NEUROSURGERY
- NFκB-dependent Control ofBACE1Promoter Transactivation by Aβ42
- (2008) Virginie Buggia-Prevot et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1
- (2008) M. Thiyagarajan et al. JOURNAL OF NEUROSCIENCE
- Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
- (2008) May H. Han et al. NATURE
- ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration
- (2008) Zhihui Zhong et al. NATURE NEUROSCIENCE
- Differential Neuroprotection and Risk for Bleeding From Activated Protein C With Varying Degrees of Anticoagulant Activity
- (2008) Yaoming Wang et al. STROKE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started